Conte Marisa L, Liu Jing, Schnell Santiago, Omary M Bishr
Taubman Health Sciences Library.
Michigan Institute for Data Science, University of Michigan.
JCI Insight. 2017 Jun 15;2(12). doi: 10.1172/jci.insight.95206.
The US continues to lead the world in research and development (R&D) expenditures, but there is concern that stagnation in federal support for biomedical research in the US could undermine the leading role the US has played in biomedical and clinical research discoveries. As a readout of research output in the US compared with other countries, assessment of original research articles published by US-based authors in ten clinical and basic science journals during 2000 to 2015 showed a steady decline of articles in high-ranking journals or no significant change in mid-ranking journals. In contrast, publication output originating from China-based investigators, in both high- and mid-ranking journals, has steadily increased commensurate with significant growth in R&D expenditures. These observations support the current concerns of stagnant and year-to-year uncertainty in US federal funding of biomedical research.
美国在研发支出方面继续领先世界，但有人担心，美国联邦政府对生物医学研究支持的停滞可能会削弱美国在生物医学和临床研究发现方面所发挥的主导作用。作为美国与其他国家研究产出的一项数据显示，对2000年至2015年期间美国作者在十种临床和基础科学期刊上发表的原创研究文章的评估表明，高排名期刊上的文章数量稳步下降，而中排名期刊上的文章数量没有显著变化。相比之下，来自中国研究人员在高排名和中排名期刊上的发表量都随着研发支出的显著增长而稳步增加。这些观察结果支持了当前对美国联邦生物医学研究资金停滞和逐年不确定性的担忧。
